How big is the Global Digital PCR Market?

The Global Digital PCR Market size is expected to reach USD 0.69 billion in 2024 and grow at a CAGR of 16.74% to reach USD 1.51 billion by 2029. Read More

What is the current Global Digital PCR Market size?

In 2024, the Global Digital PCR Market size is expected to reach USD 0.69 billion. Read More

Who are the key players in Global Digital PCR Market?

Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc, Sysmex Corporation, JN Medsys and Fluidigm Corporatio are the major companies operating in the Global Digital PCR Market. Read More

Which is the fastest growing region in Global Digital PCR Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Digital PCR Market?

In 2024, the North America accounts for the largest market share in Global Digital PCR Market. Read More

What years does this Global Digital PCR Market cover, and what was the market size in 2023?

In 2023, the Global Digital PCR Market size was estimated at USD 0.59 billion. The report covers the Global Digital PCR Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Digital PCR Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Digital PCR Market - Size, Share & Industry Analysis

Digital PCR Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Real-Time & Digital PCR Market is segmented by Product Type (Digital PCR equipment, Consumables, and reagents, Software and Services), Technology (Droplet Digital PCR and BEAMing Digital PCR), Application (Clinical Diagnostics, Research and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market size and value (in USD million) for the above segments.

Digital PCR Industry Overview

The digital PCR market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Bio-Rad Laboratories Inc., Thermo Fisher Scientific, Sysmex Corporation, Fluidigm Corporation, JN Medsys, QIAGEN, Merck KGaA, Stilla, and Avance Biosciences.